← Leaderboards
Andrew Robert Sas
University Of Michigan At Ann Arbor
$1,745,841
Attributed
$1,745,841
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $458.5K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,745,841 · 2
By mechanism
K08$897,585 · 1
R01$848,256 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Carole Anne Parent$1,887,441
- Jason Knight$7,353,823
- Sung Won Choi$6,756,881
- Daniel G. Remick$12,614,334
- Mimi S Takami$675,880
Others in their field
Other Emerging Leaders on “Immunoregulation”
- Gary Fanger · Rise Therapeutics, Llc$13,175,019
- Florence Burleson · Brt-Burleson Research Technologies, Inc.$11,287,326
- Avnesh Sinh Thakor · Stanford University$7,297,208
- Chun-Jun Guo · Weill Medical Coll Of Cornell Univ$6,414,222
- Zachary Scott Morris · University Of Wisconsin-Madison$5,484,494
- Peter The Sage · Brigham And Women'S Hospital$5,449,413
Research focus
ImmunoregulationInjuryExperimental StudyImmunological ModelsInflammatory ResponseInjectionsCoculture TechniquesCytoprotectionGlaucomaImmuneImmunotherapyInflammationBlindnessArginaseAnimal ModelCell WallCd14 GeneCrush InjuryCell InjuryAxonCellsAcuteAxon RegenerationIn Vitro
Grant awards (7)
Arginase positive monocyte mediated RGC neuroprotection after traumatic optic neuropathy$389,739
R01 · FY2025 · EY · contact PI
Arginase positive monocyte mediated RGC neuroprotection after traumatic optic neuropathy$458,517
R01 · FY2024 · EY · contact PI
Neutrophil driven recovery from traumatic and ischemic optic neuropathy$179,517
K08 · FY2022 · EY · contact PI
Neutrophil driven recovery from traumatic and ischemic optic neuropathy$179,517
K08 · FY2021 · EY · contact PI
Neutrophil driven recovery from traumatic and ischemic optic neuropathy$179,517
K08 · FY2020 · EY · contact PI
Neutrophil driven recovery from traumatic and ischemic optic neuropathy$179,517
K08 · FY2019 · EY · contact PI
Neutrophil driven recovery from traumatic and ischemic optic neuropathy$179,517
K08 · FY2018 · EY · contact PI